Brief: Artificial heart maker CARMAT announces positive data for its Aeson product
Nov 13 (Reuters) - Carmat SA ALCAR.PA :
* MILESTONE OF 30 HEART TRANSPLANTS POST AESON® SUPPORT,
PASSED
* GROWING ADOPTION OF AESON® AS A BRIDGE-TO-TRANSPLANT
SOLUTION IN
EUROPE
* OUT OF THESE 30 TRANSPLANTS CARRIED OUT IN 7 DIFFERENT
COUNTRIES
(INCLUDING 16 IN FRANCE AND 5 IN GERMANY), 16 HAVE BEEN
PERFORMED SINCE BEGINNING OF 2024
Source text: ID:nBw7ryq4Da
Further company coverage: ALCAR.PA
(Reporting by Sudip Kar-Gupta)
((sudip.kargupta@thomsonreuters.com;))
Recent news on Carmat SA
See all newsBrief: Carmat Receives Takeover Bid
Brief: Carmat SAS Submits Bid For Carmat SA Within Ongoing Receivership Procedure
Brief: Carmat Says Liquidation Review Postponed Until Nov 25
Brief: Carmat: Judiciary Administrator Has Submitted Request To Convert Receivership Into Liquidation To Court
Carmat says imminent liquidation now 'extremely probable'